Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)

J. Douglas, D. Smith, G. Jorgensen (Brisbane, Australia)

Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Session: Sleep disorders: neurology, smoking and daytime sleepiness
Session type: Thematic Poster Session
Number: 952
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Douglas, D. Smith, G. Jorgensen (Brisbane, Australia). Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS). Eur Respir J 2010; 36: Suppl. 54, 952

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006

Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010

Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Predictors of sleepiness in obstructive sleep apnoea at baseline and after 6 months of continuous positive airway pressure therapy
Source: Eur Respir J, 50 (5) 1700348; 10.1183/13993003.00348-2017
Year: 2017



Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Does positional apnea influence optimum continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA)?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003

Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012